Re: ampyra
Anonymous member feedback:
"We have developed criteria recommending a prior authorization as well as a quantity limit. The prior auth would require prescribing by a neurologist, diagnosis of MS, currently on disease-modifying therapy for MS, and limited to quantity of 60 for 30/days. Increasing dose beyond 10mg twice a day did not achieve any additional clinical benefit but did increase risk for side effects including seizures"
|